Chicken
Taxonomy: Cellular organisms; Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata; Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Sauropsida; Sauria; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes; Phasianidae; Phasianinae; Gallus,
Latin Name:
Gallus gallus
Tested tissues: PrimitiveStreak, AnteriorNeuralTube, TotalBrain,
Data set information
| Project | Date | Technology | Tissue | Condition | Cell | PMID/DOI |
|---|---|---|---|---|---|---|
| Vthunter_1025 | 2018.07 | Fluidigm C1 | PrimitiveStreak | Normal | 175 | Link |
| Vthunter_1006 | 2017.12 | SMART-seq | AnteriorNeuralTube | Normal | 500 | Link |
| Vthunter_110067 | 2019.12 | MARS-seq | TotalBrain | Normal | 768 | Link |
| Virus | Virus Name | GeneTop 5 cell types expressing viral receptor ordered by expression proportion |
|---|---|---|
|
Dengue virus |
PrimitiveStreak-embryonic cell : 100.00% ; AnteriorNeuralTube-neural crest cell : 99.80% ; TotalBrain-Immune cells : 1.43% ; PrimitiveStreak-embryonic cell : 100.00% ; AnteriorNeuralTube-neural crest cell : 79.04% ; TotalBrain-Immune cells : 0.00% ; PrimitiveStreak-embryonic cell : 92.57% ; AnteriorNeuralTube-neural crest cell : 62.87% ; TotalBrain-Immune cells : 0.39% ; |
|
Adeno-associated virus 9 |
PrimitiveStreak-embryonic cell : 100.00% ; AnteriorNeuralTube-neural crest cell : 99.80% ; TotalBrain-Immune cells : 1.43% ; |
|
Chikungunya virus | |
|
Classical swine fever virus |
PrimitiveStreak-embryonic cell : 100.00% ; AnteriorNeuralTube-neural crest cell : 99.80% ; TotalBrain-Immune cells : 1.43% ; |
|
Adeno-associated virus - 3 |
PrimitiveStreak-embryonic cell : 100.00% ; AnteriorNeuralTube-neural crest cell : 99.80% ; TotalBrain-Immune cells : 1.43% ; |
|
Simian rotavirus A strain RRV |
PrimitiveStreak-embryonic cell : 100.00% ; AnteriorNeuralTube-neural crest cell : 100.00% ; TotalBrain-Immune cells : 29.43% ; PrimitiveStreak-embryonic cell : 100.00% ; AnteriorNeuralTube-neural crest cell : 97.01% ; TotalBrain-Immune cells : 38.93% ; AnteriorNeuralTube-neural crest cell : 64.07% ; PrimitiveStreak-embryonic cell : 60.00% ; TotalBrain-Immune cells : 14.58% ; AnteriorNeuralTube-neural crest cell : 40.52% ; PrimitiveStreak-embryonic cell : 22.29% ; PrimitiveStreak-embryonic cell : 21.71% ; AnteriorNeuralTube-neural crest cell : 13.57% ; TotalBrain-Immune cells : 0.00% ; |
|
Human betaherpesvirus 5 |
PrimitiveStreak-embryonic cell : 100.00% ; AnteriorNeuralTube-neural crest cell : 97.01% ; TotalBrain-Immune cells : 38.93% ; PrimitiveStreak-embryonic cell : 90.29% ; AnteriorNeuralTube-neural crest cell : 27.94% ; TotalBrain-Immune cells : 0.52% ; AnteriorNeuralTube-neural crest cell : 64.07% ; PrimitiveStreak-embryonic cell : 60.00% ; TotalBrain-Immune cells : 14.58% ; AnteriorNeuralTube-neural crest cell : 43.31% ; PrimitiveStreak-embryonic cell : 3.43% ; TotalBrain-Immune cells : 0.00% ; |
|
Venezuelan equine encephalitis virus |
PrimitiveStreak-embryonic cell : 100.00% ; AnteriorNeuralTube-neural crest cell : 99.80% ; TotalBrain-Immune cells : 1.43% ; |
|
Human gammaherpesvirus 4 |
PrimitiveStreak-embryonic cell : 100.00% ; AnteriorNeuralTube-neural crest cell : 97.01% ; TotalBrain-Immune cells : 38.93% ; AnteriorNeuralTube-neural crest cell : 49.70% ; PrimitiveStreak-embryonic cell : 1.71% ; TotalBrain-Immune cells : 0.00% ; PrimitiveStreak-embryonic cell : 1.14% ; AnteriorNeuralTube-neural crest cell : 1.00% ; |
|
Human metapneumovirus |
PrimitiveStreak-embryonic cell : 100.00% ; AnteriorNeuralTube-neural crest cell : 97.01% ; TotalBrain-Immune cells : 38.93% ; |
|
Hepacivirus C |
PrimitiveStreak-embryonic cell : 100.00% ; AnteriorNeuralTube-neural crest cell : 94.81% ; TotalBrain-Immune cells : 20.05% ; PrimitiveStreak-embryonic cell : 100.00% ; AnteriorNeuralTube-neural crest cell : 79.04% ; TotalBrain-Immune cells : 0.00% ; PrimitiveStreak-embryonic cell : 90.29% ; AnteriorNeuralTube-neural crest cell : 27.94% ; TotalBrain-Immune cells : 0.52% ; PrimitiveStreak-embryonic cell : 81.14% ; AnteriorNeuralTube-neural crest cell : 69.66% ; TotalBrain-Immune cells : 3.39% ; AnteriorNeuralTube-neural crest cell : 44.71% ; PrimitiveStreak-embryonic cell : 40.57% ; TotalBrain-Immune cells : 0.00% ; AnteriorNeuralTube-neural crest cell : 18.96% ; PrimitiveStreak-embryonic cell : 8.00% ; TotalBrain-Immune cells : 7.03% ; TotalBrain-Immune cells : 0.00% ; |
|
Human parvovirus B19 |
PrimitiveStreak-embryonic cell : 100.00% ; AnteriorNeuralTube-neural crest cell : 97.01% ; TotalBrain-Immune cells : 38.93% ; |
|
Lassa mammarenavirus |
PrimitiveStreak-embryonic cell : 100.00% ; AnteriorNeuralTube-neural crest cell : 95.61% ; TotalBrain-Immune cells : 30.73% ; PrimitiveStreak-embryonic cell : 92.57% ; AnteriorNeuralTube-neural crest cell : 62.87% ; TotalBrain-Immune cells : 0.39% ; PrimitiveStreak-embryonic cell : 83.43% ; AnteriorNeuralTube-neural crest cell : 50.10% ; TotalBrain-Immune cells : 2.21% ; |
|
Equid alphaherpesvirus 1 | |
|
Adeno-associated virus - 8 |
PrimitiveStreak-embryonic cell : 100.00% ; AnteriorNeuralTube-neural crest cell : 99.80% ; TotalBrain-Immune cells : 1.43% ; |
|
Mammalian orthoreovirus |
PrimitiveStreak-embryonic cell : 100.00% ; AnteriorNeuralTube-neural crest cell : 97.01% ; TotalBrain-Immune cells : 38.93% ; AnteriorNeuralTube-neural crest cell : 40.52% ; PrimitiveStreak-embryonic cell : 22.29% ; AnteriorNeuralTube-neural crest cell : 32.73% ; PrimitiveStreak-embryonic cell : 17.14% ; TotalBrain-Immune cells : 0.00% ; |
|
Echovirus E8 | |
|
Foot-and-mouth disease virus |
PrimitiveStreak-embryonic cell : 100.00% ; AnteriorNeuralTube-neural crest cell : 97.01% ; TotalBrain-Immune cells : 38.93% ; AnteriorNeuralTube-neural crest cell : 64.07% ; PrimitiveStreak-embryonic cell : 60.00% ; TotalBrain-Immune cells : 14.58% ; PrimitiveStreak-embryonic cell : 16.57% ; AnteriorNeuralTube-neural crest cell : 12.57% ; TotalBrain-Immune cells : 0.00% ; PrimitiveStreak-embryonic cell : 12.00% ; TotalBrain-Immune cells : 0.00% ; |
|
Adeno-associated virus - 2 |
PrimitiveStreak-embryonic cell : 100.00% ; AnteriorNeuralTube-neural crest cell : 97.01% ; TotalBrain-Immune cells : 38.93% ; PrimitiveStreak-embryonic cell : 100.00% ; AnteriorNeuralTube-neural crest cell : 99.80% ; TotalBrain-Immune cells : 1.43% ; AnteriorNeuralTube-neural crest cell : 79.64% ; PrimitiveStreak-embryonic cell : 77.71% ; TotalBrain-Immune cells : 5.47% ; |
|
Sindbis virus |
PrimitiveStreak-embryonic cell : 100.00% ; AnteriorNeuralTube-neural crest cell : 99.80% ; TotalBrain-Immune cells : 1.43% ; |
|
Echovirus E1 | |
|
Human rotavirus strain WA |
PrimitiveStreak-embryonic cell : 100.00% ; AnteriorNeuralTube-neural crest cell : 97.01% ; TotalBrain-Immune cells : 38.93% ; AnteriorNeuralTube-neural crest cell : 40.52% ; PrimitiveStreak-embryonic cell : 22.29% ; PrimitiveStreak-embryonic cell : 21.71% ; AnteriorNeuralTube-neural crest cell : 13.57% ; TotalBrain-Immune cells : 0.00% ; |
|
Feline leukemia virus strain B/lambda-B1 | |
|
Amphotropic murine leukemia virus |
PrimitiveStreak-embryonic cell : 94.29% ; AnteriorNeuralTube-neural crest cell : 67.86% ; TotalBrain-Immune cells : 1.17% ; |
|
Gibbon ape leukemia virus | |
|
Rabies lyssavirus | |
|
Ebola virus |
PrimitiveStreak-embryonic cell : 92.57% ; AnteriorNeuralTube-neural crest cell : 62.87% ; TotalBrain-Immune cells : 0.39% ; AnteriorNeuralTube-neural crest cell : 66.07% ; PrimitiveStreak-embryonic cell : 61.71% ; TotalBrain-Immune cells : 1.17% ; AnteriorNeuralTube-neural crest cell : 61.08% ; PrimitiveStreak-embryonic cell : 52.57% ; TotalBrain-Immune cells : 6.12% ; |
|
Marburg marburgvirus | |
|
Lymphocytic choriomeningitis mammarenavirus | |
|
Zika virus |
PrimitiveStreak-embryonic cell : 92.57% ; AnteriorNeuralTube-neural crest cell : 62.87% ; TotalBrain-Immune cells : 0.39% ; |
|
Xenotropic murine leukemia virus |
AnteriorNeuralTube-neural crest cell : 90.82% ; PrimitiveStreak-embryonic cell : 82.29% ; TotalBrain-Immune cells : 2.08% ; |
|
Polytropic murine leukemia virus |
AnteriorNeuralTube-neural crest cell : 90.82% ; PrimitiveStreak-embryonic cell : 82.29% ; TotalBrain-Immune cells : 2.08% ; |
|
Influenza A virus |
PrimitiveStreak-embryonic cell : 90.29% ; AnteriorNeuralTube-neural crest cell : 27.94% ; TotalBrain-Immune cells : 0.52% ; AnteriorNeuralTube-neural crest cell : 80.64% ; PrimitiveStreak-embryonic cell : 78.29% ; TotalBrain-Immune cells : 1.82% ; AnteriorNeuralTube-neural crest cell : 45.11% ; PrimitiveStreak-embryonic cell : 26.29% ; TotalBrain-Immune cells : 4.04% ; PrimitiveStreak-embryonic cell : 32.00% ; AnteriorNeuralTube-neural crest cell : 30.54% ; |
|
Human immunodeficiency virus 1 | |
|
Feline immunodeficiency virus |
AnteriorNeuralTube-neural crest cell : 86.03% ; PrimitiveStreak-embryonic cell : 84.00% ; TotalBrain-Immune cells : 6.64% ; |
|
Human immunodeficiency virus 2 |
AnteriorNeuralTube-neural crest cell : 86.03% ; PrimitiveStreak-embryonic cell : 84.00% ; TotalBrain-Immune cells : 6.64% ; |
|
Varicella Zoster Virus |
PrimitiveStreak-embryonic cell : 85.71% ; AnteriorNeuralTube-neural crest cell : 81.44% ; TotalBrain-Immune cells : 2.34% ; |
|
Human alphaherpesvirus 3 |
PrimitiveStreak-embryonic cell : 85.71% ; AnteriorNeuralTube-neural crest cell : 81.44% ; TotalBrain-Immune cells : 2.34% ; |
|
Latino mammarenavirus |
PrimitiveStreak-embryonic cell : 83.43% ; AnteriorNeuralTube-neural crest cell : 50.10% ; TotalBrain-Immune cells : 2.21% ; |
|
Oliveros mammarenavirus |
PrimitiveStreak-embryonic cell : 83.43% ; AnteriorNeuralTube-neural crest cell : 50.10% ; TotalBrain-Immune cells : 2.21% ; |
|
Hendra henipavirus |
PrimitiveStreak-embryonic cell : 83.43% ; AnteriorNeuralTube-neural crest cell : 32.34% ; TotalBrain-Immune cells : 0.00% ; |
|
Nipah henipavirus |
PrimitiveStreak-embryonic cell : 83.43% ; AnteriorNeuralTube-neural crest cell : 32.34% ; TotalBrain-Immune cells : 0.00% ; |
|
Human papillomavirus type 16 | |
|
Porcine reproductive and respiratory syndrome virus |
AnteriorNeuralTube-neural crest cell : 83.23% ; PrimitiveStreak-embryonic cell : 82.29% ; TotalBrain-Immune cells : 2.73% ; |
|
Canine parvovirus |
PrimitiveStreak-embryonic cell : 81.14% ; AnteriorNeuralTube-neural crest cell : 69.66% ; TotalBrain-Immune cells : 3.39% ; |
|
Argentinian mammarenavirus |
PrimitiveStreak-embryonic cell : 81.14% ; AnteriorNeuralTube-neural crest cell : 69.66% ; TotalBrain-Immune cells : 3.39% ; |
|
Guanarito mammarenavirus |
PrimitiveStreak-embryonic cell : 81.14% ; AnteriorNeuralTube-neural crest cell : 69.66% ; TotalBrain-Immune cells : 3.39% ; |
|
Feline panleukopenia virus |
PrimitiveStreak-embryonic cell : 81.14% ; AnteriorNeuralTube-neural crest cell : 69.66% ; TotalBrain-Immune cells : 3.39% ; |
|
Mouse mammary tumor virus |
PrimitiveStreak-embryonic cell : 81.14% ; AnteriorNeuralTube-neural crest cell : 69.66% ; TotalBrain-Immune cells : 3.39% ; |
|
Machupo mammarenavirus |
PrimitiveStreak-embryonic cell : 81.14% ; AnteriorNeuralTube-neural crest cell : 69.66% ; TotalBrain-Immune cells : 3.39% ; |
|
Coxsackievirus A16 |
AnteriorNeuralTube-neural crest cell : 79.24% ; PrimitiveStreak-embryonic cell : 69.14% ; TotalBrain-Immune cells : 1.30% ; |
|
Enterovirus A71 |
AnteriorNeuralTube-neural crest cell : 79.24% ; PrimitiveStreak-embryonic cell : 69.14% ; TotalBrain-Immune cells : 1.30% ; |
|
Human mastadenovirus C | |
|
Bovine alphaherpesvirus 1 |
PrimitiveStreak-embryonic cell : 73.71% ; AnteriorNeuralTube-neural crest cell : 36.33% ; TotalBrain-Immune cells : 0.00% ; |
|
Human alphaherpesvirus 1 |
PrimitiveStreak-embryonic cell : 73.71% ; AnteriorNeuralTube-neural crest cell : 36.33% ; TotalBrain-Immune cells : 0.00% ; AnteriorNeuralTube-neural crest cell : 64.07% ; PrimitiveStreak-embryonic cell : 60.00% ; TotalBrain-Immune cells : 14.58% ; PrimitiveStreak-embryonic cell : 16.57% ; AnteriorNeuralTube-neural crest cell : 12.57% ; TotalBrain-Immune cells : 0.00% ; PrimitiveStreak-embryonic cell : 12.00% ; TotalBrain-Immune cells : 0.00% ; |
|
Human alphaherpesvirus 2 |
PrimitiveStreak-embryonic cell : 73.71% ; AnteriorNeuralTube-neural crest cell : 36.33% ; TotalBrain-Immune cells : 0.00% ; |
|
Suid alphaherpesvirus 1 |
PrimitiveStreak-embryonic cell : 73.71% ; AnteriorNeuralTube-neural crest cell : 36.33% ; TotalBrain-Immune cells : 0.00% ; |
|
Human gammaherpesvirus 8 |
AnteriorNeuralTube-neural crest cell : 64.07% ; PrimitiveStreak-embryonic cell : 60.00% ; TotalBrain-Immune cells : 14.58% ; |
|
Coxsackievirus B1 | |
|
Human parechovirus 1 |
AnteriorNeuralTube-neural crest cell : 64.07% ; PrimitiveStreak-embryonic cell : 60.00% ; TotalBrain-Immune cells : 14.58% ; |
|
West Nile virus |
AnteriorNeuralTube-neural crest cell : 64.07% ; PrimitiveStreak-embryonic cell : 60.00% ; TotalBrain-Immune cells : 14.58% ; |
|
Coxsackievirus A9 | |
|
Severe acute respiratory syndrome coronavirus 2 |
PrimitiveStreak-embryonic cell : 49.71% ; AnteriorNeuralTube-neural crest cell : 39.92% ; TotalBrain-Immune cells : 0.91% ; AnteriorNeuralTube-neural crest cell : 18.96% ; PrimitiveStreak-embryonic cell : 8.00% ; TotalBrain-Immune cells : 7.03% ; PrimitiveStreak-embryonic cell : 3.43% ; AnteriorNeuralTube-neural crest cell : 1.40% ; TotalBrain-Immune cells : 0.00% ; |
|
Sin Nombre orthohantavirus |
PrimitiveStreak-embryonic cell : 47.43% ; AnteriorNeuralTube-neural crest cell : 21.16% ; TotalBrain-Immune cells : 0.00% ; |
|
Andes orthohantavirus |
PrimitiveStreak-embryonic cell : 47.43% ; AnteriorNeuralTube-neural crest cell : 21.16% ; TotalBrain-Immune cells : 0.00% ; |
|
Simian sarcoma-associated virus |
AnteriorNeuralTube-neural crest cell : 47.11% ; PrimitiveStreak-embryonic cell : 13.71% ; TotalBrain-Immune cells : 0.65% ; |
|
Ecotropic murine leukemia virus |
PrimitiveStreak-embryonic cell : 46.86% ; AnteriorNeuralTube-neural crest cell : 44.51% ; TotalBrain-Immune cells : 0.00% ; |
|
Vesicular stomatitis virus |
AnteriorNeuralTube-neural crest cell : 45.11% ; PrimitiveStreak-embryonic cell : 26.29% ; TotalBrain-Immune cells : 4.04% ; |
|
Canine coronavirus |
AnteriorNeuralTube-neural crest cell : 43.31% ; PrimitiveStreak-embryonic cell : 3.43% ; TotalBrain-Immune cells : 0.00% ; |
|
Human coronavirus 229E |
AnteriorNeuralTube-neural crest cell : 43.31% ; PrimitiveStreak-embryonic cell : 3.43% ; TotalBrain-Immune cells : 0.00% ; |
|
Feline coronavirus |
AnteriorNeuralTube-neural crest cell : 43.31% ; PrimitiveStreak-embryonic cell : 3.43% ; TotalBrain-Immune cells : 0.00% ; |
|
Transmissible gastroenteritis virus |
AnteriorNeuralTube-neural crest cell : 43.31% ; PrimitiveStreak-embryonic cell : 3.43% ; TotalBrain-Immune cells : 0.00% ; |
|
Infectious bronchitis virus |
AnteriorNeuralTube-neural crest cell : 43.31% ; PrimitiveStreak-embryonic cell : 3.43% ; TotalBrain-Immune cells : 0.00% ; |
|
Porcine epidemic diarrhea virus |
AnteriorNeuralTube-neural crest cell : 43.31% ; PrimitiveStreak-embryonic cell : 3.43% ; TotalBrain-Immune cells : 0.00% ; |
|
Feline calicivirus |
AnteriorNeuralTube-neural crest cell : 40.52% ; PrimitiveStreak-embryonic cell : 22.29% ; |
|
Coxsackievirus A10 |
AnteriorNeuralTube-neural crest cell : 34.93% ; PrimitiveStreak-embryonic cell : 29.14% ; TotalBrain-Immune cells : 0.00% ; |
|
Feline leukemia virus strain C/FA27 |
PrimitiveStreak-embryonic cell : 32.00% ; AnteriorNeuralTube-neural crest cell : 27.15% ; TotalBrain-Immune cells : 0.26% ; |
|
Jaagsiekte sheep retrovirus |
AnteriorNeuralTube-neural crest cell : 26.15% ; PrimitiveStreak-embryonic cell : 15.43% ; TotalBrain-Immune cells : 0.13% ; |
|
Simian immunodeficiency virus |
TotalBrain-Immune cells : 20.83% ; |
|
Hepatitis E virus |
AnteriorNeuralTube-neural crest cell : 16.97% ; PrimitiveStreak-embryonic cell : 10.29% ; TotalBrain-Immune cells : 0.13% ; |
|
Mayaro virus |
PrimitiveStreak-embryonic cell : 15.43% ; AnteriorNeuralTube-neural crest cell : 10.78% ; TotalBrain-Immune cells : 0.52% ; |
|
Onyong-nyong virus |
PrimitiveStreak-embryonic cell : 15.43% ; AnteriorNeuralTube-neural crest cell : 10.78% ; TotalBrain-Immune cells : 0.52% ; |
|
Ross River virus |
PrimitiveStreak-embryonic cell : 15.43% ; AnteriorNeuralTube-neural crest cell : 10.78% ; TotalBrain-Immune cells : 0.52% ; |
|
Canine morbillivirus |
AnteriorNeuralTube-neural crest cell : 12.18% ; |
|
Measles morbillivirus |
AnteriorNeuralTube-neural crest cell : 12.18% ; |
|
Small ruminant morbillivirus |
AnteriorNeuralTube-neural crest cell : 12.18% ; |
|
Respiratory syncytial virus |
TotalBrain-Immune cells : 8.98% ; |
|
Bovine leukemia virus |
TotalBrain-Immune cells : 4.69% ; |
|
Human coronavirus NL63 |
PrimitiveStreak-embryonic cell : 3.43% ; AnteriorNeuralTube-neural crest cell : 1.40% ; TotalBrain-Immune cells : 0.00% ; |
|
SARS coronavirus |
PrimitiveStreak-embryonic cell : 3.43% ; AnteriorNeuralTube-neural crest cell : 1.40% ; TotalBrain-Immune cells : 0.00% ; |
|
Encephalomyocarditis virus |
AnteriorNeuralTube-neural crest cell : 1.60% ; |
|
JC polyomavirus |
AnteriorNeuralTube-neural crest cell : 1.40% ; TotalBrain-Immune cells : 0.00% ; |
|
Rubella virus |
AnteriorNeuralTube-neural crest cell : 1.00% ; |
|
Human mastadenovirus B |
TotalBrain-Immune cells : 0.52% ; |
|
Rhinovirus C |
TotalBrain-Immune cells : 0.13% ; |
|
Middle East respiratory syndrome-related coronavirus |
TotalBrain-Immune cells : 0.13% ; |